Eli Lilly's new obesity drug sets weight-loss records, surpassing Mounjaro

Eli Lilly is preparing to launch a new obesity drug that the company says delivers unprecedented levels of weight loss. Patrik Jönsson, a senior executive at the US pharmaceutical giant, stated: "We have never seen this level of weight reduction before." The development puts Eli Lilly firmly ahead of Danish rival Novo Nordisk.